Article Text

ASSA13-03-22 The Relation Between Mitofusin-2 and b3-Adrenergic Receptor and Its Possible Mechanism in Chronic Heart Failure
  1. Kong Yi-hui,
  2. Lai Zeng-hua,
  3. Di Ning-ning,
  4. Li Wei-min
  1. Department of Cardiology, The First Affiliated Hospital of Harbin Medical University


Objective To investigate the effects of β3-adrenergic receptor (β3-AR) on apoptosis and its possible mechanism of rats with isoproterenol (ISO)-induced chronic heart failure (HF).

Methods (1) The rats were randomly divided into three groups: 7 weight– matched normal adult rats as controls, 18 rats with ISO induced heart failure and 21 rats with ISO induced heart failure but received SR59230A treatment for 6 weeks. (2) Echocardiography examinated left ventricular ejection fraction (EF), early peak diastolic velocity/late peak diastolic velocity (E/A), fractional shortening (FS), left ventricular end diastolic diameter (LVEDD) and left ventricular end systolic diameter (LVESD). (3) Ratio of left ventricular weight and body weight (LVW/BW) was calculated. (4) The expression levels of β3-AR, mitofusin-2 (Mfn2) and Caspase-3 mRNA in myocardium were detected by reverse transcriptio-polymerase chain reaction (RT-PCR). (5) The expression of β3-AR, Mfn2, Caspase-, receptor serine/threonine kinases (Akt) and p-Akt protein were detected by western blot.

Results (1) Compared with control group, the cardiac function of ISO group aggravated, LVW/BW and β3-AR mRNA expression increased in heart failure rats; these changes significantly reduced in ISO+SR59230A group. (2) In ISO group, the expression of β3-AR, Mfn2 and Caspase-3 protein rised as well as Akt decreased in relative to control group, myocardial apoptosis was significantly increased and that reverse significantly in ISO+SR59230A group.

Conclusions In heart failure, the expression of β3-AR increased, SR59230A inhibited β3-AR and Mfn2, β3-AR induced cardiomyocyte apoptosis through Mfn2. Mfn2 may become new therapeutic benefits with heart failure.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.